Dr. Amanda Kong on High Versus Low Volume Hospitals in the Treatment of Breast Cancer
​Amanda L. Kong, MD, MS, FACS, discusses breast cancer care at high volume hospitals versus low volume hospitals. Kong says the study is the first one that looks at processes as a bundle and takes into account socioeconomic statuses of patients.
Amanda L. Kong, MD, MS, FACS, associate professor, Medical College of Wisconsin, discusses breast cancer care at high volume hospitals versus low volume hospitals. Kong says the study is the first one that looks at processes as a bundle and takes into account socioeconomic statuses of patients. Kong adds that the study shows that high volume hospitals produce better survival rates than low volume hospitals.
The study gathered socioeconomic and sociodemographic information from women with breast cancer through a survey. In the future, Kong said she hopes to continue the study in a more contemporary group of patients, especially now that sentinel lymph node therapy has become the standard of care in breast cancer.
Enasidenib Shows Promise as Post-Transplant Maintenance in IDH2-Mutated AML
January 7th 2025Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic stem cell transplant maintenance therapy for IDH2-mutated acute myeloid leukemia treatment.
Read More
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
